Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2- HIV Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT02556086
What this trial is testing

A Phase 2b Evaluation of Daclatasvir/Sofosbuvir in Non-Cirrhotic Treatment Naive Subjects With Genotype 1, 2, 3 and 4 Chronic Hepatitis C Virus Coinfected With Human Immunodeficiency Virus (HIV-1)

Who this might be right for
Hepatitis C
Bristol-Myers Squibb
Post-approval studies (Phase 4)Study completedNCT00527618
What this trial is testing

Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV

Who this might be right for
Genital HerpesHIV Infection
University of Washington 28
Large-scale testing (Phase 3)Study completedNCT00002397
What this trial is testing

Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney Disease

Who this might be right for
HIV InfectionsAIDS-Associated Nephropathy
Hoffmann-La Roche 24
Early research (Phase 1)Study completedNCT00775125
What this trial is testing

VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state.

Who this might be right for
Hepatitis CTelaprevirHIV
Tibotec BVBA 40
Testing effectiveness (Phase 2)UnknownNCT00005118
What this trial is testing

The Safety and Effectiveness of Indinavir Plus Ritonavir Plus Two NRTIs in HIV-Infected Patients Who Need Early Intervention Treatment

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 100
Not applicableStudy completedNCT00602550
What this trial is testing

Bioequivalency Study of Zidovudine Under Fasting Conditions

Who this might be right for
HIV Infections
Roxane Laboratories 52
Not applicableStudy completedNCT00458562
What this trial is testing

Identifying Genes That Predict Risk of Developing Cervical Intraepithelial Neoplasia or Invasive Cervical Cancer

Who this might be right for
Cervical CancerPrecancerous Condition
University of Washington 1,680
Large-scale testing (Phase 3)Study completedNCT00005918
What this trial is testing

Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients

Who this might be right for
HIV Infections
Bristol-Myers Squibb 730
Not applicableLooking for participantsNCT06834113
What this trial is testing

Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset

Who this might be right for
HIV I InfectionInjection Pain
Centre Hospitalier Régional d'Orléans 120
Testing effectiveness (Phase 2)Study completedNCT00000924
What this trial is testing

Compare Two Different Anti-HIV Drug Regimens

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Not applicableStudy completedNCT02125773
What this trial is testing

Pre-exposure Prophylaxis Accessibility Research and Evaluation 2

Who this might be right for
PrEP UptakeHIV Seronegativity
University of California, San Diego 150
Not applicableStudy completedNCT00002394
What this trial is testing

Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment

Who this might be right for
Candidiasis, OralHIV Infections
Novartis 30
Not applicableUnknownNCT05823779
What this trial is testing

A 48 Week Observational Study of the Frequency of Symptomatic Herpes Virus I and II in HIV Infected Subjects

Who this might be right for
HIV DiseaseHerpes Simplex 1Herpes Simplex 2
Global Research Institute 50
Post-approval studies (Phase 4)Study completedNCT00344461
What this trial is testing

A Two Year Study of the Clinical Efficacy of the Combination of Emtricitabine, Tenofovir, and Nevirapine

Who this might be right for
HIV
University of Maryland, Baltimore 54
Testing effectiveness (Phase 2)Study completedNCT00001083
What this trial is testing

Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 240
Testing effectiveness (Phase 2)Study completedNCT01138202
What this trial is testing

Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy

Who this might be right for
HIV InfectionsTuberculosis
The HIV Netherlands Australia Thailand Research Collaboration 40
Not applicableStudy completedNCT00000955
What this trial is testing

Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 864
Testing effectiveness (Phase 2)Study completedNCT00000913
What this trial is testing

Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Testing effectiveness (Phase 2)Looking for participantsNCT07227779
What this trial is testing

B-PaLMZ for TB Meningitis

Who this might be right for
Tuberculous MeningitisHIVMeningitis+1 more
David Boulware 312
Not applicableLooking for participantsNCT06444360
What this trial is testing

Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults

Who this might be right for
HIV
Westat 360
Next Page